{
    "Trade/Device Name(s)": [
        "Xpert\u00ae Xpress Flu",
        "Xpert Xpress Flu Assay",
        "Xpert\u00ae Nasopharyngeal Sample Collection Kit"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K162456",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142045",
        "K151226"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OOI",
        "JSM"
    ],
    "Summary Letter Date": "January 10, 2017",
    "Summary Letter Received Date": "January 11, 2017",
    "Submission Date": "September 01, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 866.2570",
        "21 CFR 866.2390"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Instrumentation for clinical multiplex test systems",
        "Culture Media, Non-Propagating Transport"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology",
        "POCT"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Xpert\u00ae Nasopharyngeal Sample Collection Kit (Plastic medical-grade polypropylene tube with individually-wrapped sterile swab)",
        "Viral transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert\u00ae Instrument Systems",
        "GeneXpert Dx system",
        "Infinity-48 system",
        "Infinity-80 system"
    ],
    "Method(s)/Technology(ies)": [
        "Automated multiplex real-time reverse transcriptase polymerase chain reaction (RT-PCR)"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex nucleic acid detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Cartridge",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert\u00ae Xpress Flu assay using automated multiplex RT-PCR for qualitative detection of influenza A and B viral RNA in nasopharyngeal swab specimens",
    "Indications for Use Summary": "Qualitative detection and differentiation of influenza A and B viral RNA from nasopharyngeal swab specimens in patients with signs and symptoms of respiratory infection, intended as an aid in diagnosis of influenza in conjunction with clinical and epidemiological risk factors",
    "fda_folder": "Microbiology"
}